Authors:
Helms, J
Muller, J
Schon, F
Winkler, F
Moser, L
Shehata-Dieler, W
Kastenbauer, E
Baumann, U
Rasp, G
Schorn, K
Esser, B
Baumgartner, W
Hamzavi, S
Gstottner, W
Westhofen, M
Doring, W
Dujardin, H
Albegger, K
Mair, A
Zenner, HP
Haferkamp, C
Schmitz-Salue, C
Arold, R
Sesterhenn, G
Jahnke, V
Wagner, H
Grabel, S
Bockmuhl, U
Hausler, R
Vischer, M
Kompis, M
Hildmann, H
Radu, HJ
Stark, T
Engel, A
Hildmann, A
Streitberger, C
Huttenbrink, KB
Muller-Aschoff, E
Hofmann, G
Seeling, K
Hloucal, U
von Ilberg, C
Kiefer, J
Pfennigdorff, T
Gall, V
Breitfuss, A
Stelzig, Y
Begall, K
Hey, M
Vorwerk, W
Thumfart, W
Gunkel, A
Zorowka, P
Stephan, K
Gammert, C
Mathis, A
DeMin, N
Freigang, B
Ziese, M
Stutzel, A
von Specht, H
Arnold, W
Brockmeier, SJ
Ebenhoch, H
Steinhoff, A
Zierhofer, C
Zwicknagl, M
Stobich, B
Citation: J. Helms et al., Comparison of the TEMPO plus ear-level speech processor and the CISPRO plus body-worn processor in adult MED-EL cochlear implant users, ORL-J OTO R, 63(1), 2001, pp. 31-40
Authors:
Kramer, MF
De la Chaux, R
Dreher, A
Pfrogner, E
Rasp, G
Citation: Mf. Kramer et al., Allergic rhinitis does not constitute a risk factor for obstructive sleep apnea syndrome, ACT OTO-LAR, 121(4), 2001, pp. 494-499
Authors:
Rasp, G
Kramer, MF
Ostertag, P
Kastenbauer, E
Citation: G. Rasp et al., A new staging system for nasal polyps. Influence of a combined local and systemic therapy with steroids., LARY RH OTO, 79(5), 2000, pp. 266-272
Authors:
Kramer, MF
Ostertag, P
Pfrogner, E
Rasp, G
Citation: Mf. Kramer et al., Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis, LARYNGOSCOP, 110(6), 2000, pp. 1056-1062
Citation: L. Klimek et G. Rasp, Norm values for eosinophil cationic protein in nasal secretions: influenceof specimen collection, CLIN EXP AL, 29(3), 1999, pp. 367-374